Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Seo Young Moon

Biographic Data

ID4161617
NAMESeo Young Moon
GIVEN NAMESSeo Young
FAMILY NAMEMoon
SIGNATUREMOON S Y
AFFILIATIONSWonkwang University
VERIFIEDNo
TOTAL WORKS2
TOTAL CITATIONS1
AUTHOR COUNT2
EDITOR COUNT0
FIRST PUBLICATION YEAR2011
LATEST PUBLICATION YEAR2013
H-INDEX1
  • The Effects of Phlomis umbrosa Turcz on Osteoclast Differentiation

    Open Access•Jong Min Baek, Ju Ha Park et al.•ARTICLE•Korean Journal of Physical…•2013

  • Inhibitory Effects of 1',2'-Dihydrorotenone on Osteoclast Differentiation and Bone Resorption In Vitro and In Vivo

    Kwang Jin Kim, Han Bok Kwak et al.•ARTICLE•Korean Journal of Physical…•2011•Cited by: 1•References: 1

    It is important to identify therapeutic compounds with no adverse effects for use in the chemotherapy of patients with bone-related diseases. The aim of this study was to identify a new compound that inhibits osteoclast differentiation and bone resorption. Herein, we examined the effects of 1’,2’-dihydrorotenone on osteoclast differentiation and bone resorption in vitro and in vivo. 1’,2’-dihydrorotenone inhibited receptor activator of NF-κB liga…

  • Inhibitory Effects of 1',2'-Dihydrorotenone on Osteoclast Differentiation and Bone Resorption In Vitro and In Vivo

    Kwang Jin Kim, Han Bok Kwak et al.•ARTICLE•Korean Journal of Physical…•2011•Cited by: 1•References: 1

    It is important to identify therapeutic compounds with no adverse effects for use in the chemotherapy of patients with bone-related diseases. The aim of this study was to identify a new compound that inhibits osteoclast differentiation and bone resorption. Herein, we examined the effects of 1’,2’-dihydrorotenone on osteoclast differentiation and bone resorption in vitro and in vivo. 1’,2’-dihydrorotenone inhibited receptor activator of NF-κB liga…

  • Inhibitory Effects of 1',2'-Dihydrorotenone on Osteoclast Differentiation and Bone Resorption In Vitro and In Vivo

    Kwang Jin Kim, Han Bok Kwak et al.•ARTICLE•Korean Journal of Physical…•2011•Cited by: 1•References: 1

    It is important to identify therapeutic compounds with no adverse effects for use in the chemotherapy of patients with bone-related diseases. The aim of this study was to identify a new compound that inhibits osteoclast differentiation and bone resorption. Herein, we examined the effects of 1’,2’-dihydrorotenone on osteoclast differentiation and bone resorption in vitro and in vivo. 1’,2’-dihydrorotenone inhibited receptor activator of NF-κB liga…

  • The Effects of Phlomis umbrosa Turcz on Osteoclast Differentiation

    Open Access•Jong Min Baek, Ju Ha Park et al.•ARTICLE•Korean Journal of Physical…•2013

Bone health and treatments (2 works) · Bone Metabolism and Diseases (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Osteoclast (2 works) · Activator (genetics (1 work) · Biochemistry (1 work) · Biology (1 work) · Bone marrow (1 work) · Bone resorption (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae